Until Labs
58 employees on LinkedIn · 2 known investors
Until develops reversible cryopreservation systems for human donor organs, translating cryobiology into engineered workflows across perfusion, cryoprotectants, cooling, rewarming, and organ-health assessment. The technology aims to prevent ice formation during vitrification and address the donor organ procurement and matching problem.
Investors · 2
Frequently asked questions
- What does Until Labs do?
- Until develops reversible cryopreservation systems for human donor organs, translating cryobiology into engineered workflows across perfusion, cryoprotectants, cooling, rewarming, and organ-health assessment. The technology aims to prevent ice formation during vitrification and address the donor organ procurement and matching problem.
- Who are Until Labs's investors?
- Until Labs's investors include age1, Lux Capital.